The board has recommended an additional final dividend of INR 7 per equity share (70%) for FY19, subject to the approval of the shareholders.
Hester Biosciences announced it Q4 2019 and FY19 results.
Business Overview
Q4FY19 Results:
Sales up by 30%
Profit up by 37%
FY19 Results:
Sales up by 27%
Profit up by 44%
The board of directors had declared and paid an interim dividend of INR 2 per equity share (20%) in Q1FY19 as well as on Q2FY19, totaling to INR 4 per equity share (40%).
The board has further recommended an additional final dividend of INR 7 per equity share (70%) for FY19, subject to the approval of the shareholders.
Total Dividend therefore for FY19would be INR 11 per equity share (110%) as against the INR 10per equity share (100%) for FY18.
Financial Highlights
